Dr. Pulsipher, Director of the UROC Innovations Lab, holds a joint faculty position in the Departments of Otolaryngology-Head and Neck Surgery and Molecular Pharmaceutics at the University of Utah (UoU). She is a Utah CTSI K12 Scholar, Utah VPCAT Scholar, Director of Basic Sciences and Translational Rhinology Research, Director of the PHCEU Undergraduate Summer Research Program, Member of the Utah Center for Nanomedicine, Experimental Therapeutics Group, and Head & Neck Cancers Center, and sits on the Board of Directors at GlycoMira Therapeutics. The UROC Innovations Lab is focused on developing and evaluating new disease models, therapeutics and drug delivery systems, and diagnostic solutions for upper airway diseases and head and neck oncology, as well as elucidating the pathophysiologic mechanisms underpinning these conditions.

Dr. Pulsipher received a doctoral degree in chemistry from the University of North Carolina at Chapel Hill and completed a Howard Hughes Medical Institute postdoctoral fellowship in chemical glycobiology at the California Institute of Technology. Prior to joining the UoU faculty, Dr. Pulsipher directed the research and preclinical development of new therapeutic solutions at GlycoMira Therapeutics, aimed at improving the care, quality of life, and outcomes for patients with chronic rhinosinusitis, while also evaluating the feasibility of novel cancer supportive care agents in mitigating radiation-induced oral mucositis.